Last updated on October 25, 2025
Yes, it is allowed. In the UK, individuals can legally buy and possess CBD products without a prescription, provided those products meet strict regulatory standards—especially regarding THC content and product classification. CBD itself is not a controlled substance, but products must contain less than 1 mg of THC per container and cannot make medicinal claims unless licensed.
A Legal Yes—with a Twist of Regulation
Once upon a time, cannabis was a blanket “no” in the UK—no growing, no selling, no possessing. But as science peeled back the layers of this complex plant, one compound emerged as the golden child of wellness: cannabidiol, or CBD. Unlike its psychoactive cousin THC, CBD doesn’t get you high. Instead, it’s been marketed for everything from stress relief to skincare. And in the UK, it’s not just a trend—it’s a regulated reality.
So, can you stroll into a shop and buy CBD oil without a prescription? Yes, you can. But before you fill your basket with gummies, tinctures, and bath bombs, let’s unpack the rules that make this possible.
The Legal Backbone: What Makes CBD Legal?
The UK’s approach to CBD is a careful balancing act between consumer access and public safety. According to the Home Office, pure CBD is not a controlled substance under the Misuse of Drugs Act 1971. However, most CBD products are derived from cannabis extracts, which means they can contain trace amounts of controlled cannabinoids like THC. That’s where things get technical.
To be legally sold and possessed without a prescription, a CBD product must:
- Contain less than 1 mg of THC per container, regardless of size
- Be derived from approved industrial hemp strains
- Not make any medicinal claims unless licensed as a medicine
If a product crosses any of these lines, it’s no longer just a wellness item—it’s a controlled drug. And that’s a whole different legal story.
No Prescription Needed—Unless It’s Medicine
Here’s where the Medicines and Healthcare products Regulatory Agency (MHRA) steps in. If a CBD product is marketed for medical use—say, to treat anxiety or epilepsy—it’s considered a medicine. That means it must go through rigorous testing and receive a Marketing Authorisation before it can be legally sold or prescribed.
For example, Epidyolex, a CBD-based medicine used to treat rare forms of epilepsy, is available only by prescription. But your average CBD oil from the high street? That’s a food supplement, not a medicine—so no prescription required.
Food, Novelty, and the FSA
CBD products sold as food or supplements must also pass through the Food Standards Agency (FSA). Since January 2019, CBD has been classified as a “novel food,” meaning it requires pre-market authorisation to ensure safety. While many products are still in the approval pipeline, the FSA has published a list of items linked to valid applications, allowing them to remain on the market temporarily.
But don’t be fooled—being on the list doesn’t mean a product is officially approved. It just means it’s under review. And if it’s not on the list? It shouldn’t be sold at all.
Cultural Shift and Consumer Caution
The rise of CBD in the UK reflects a broader cultural shift toward natural wellness and alternative therapies. From boutique cafés offering CBD-infused lattes to mainstream pharmacies stocking oils and capsules, the compound has found its way into everyday life.
Still, the government urges caution. The FSA recommends that healthy adults limit their intake to 10 mg of CBD per day and advises vulnerable groups—like children, pregnant women, and those on medication—to avoid it unless medically directed.
Final Thoughts
So yes, you can legally buy and possess CBD products in the UK without a prescription. But legality hinges on compliance. Products must be low in THC, free of medical claims, and—if edible—on the FSA’s novel food list. It’s a green light, but not a free-for-all.
See more on UNITED KINGDOM
Sources
Drug licensing factsheet: cannabis, CBD and other cannabinoids
https://www.gov.uk/government/publications/cannabis-cbd-and-other-cannabinoids-drug-licensing-factsheet/drug-licensing-factsheet-cannabis-cbd-and-other-cannabinoids
3 October 2024
MHRA statement on products containing cannabidiol (CBD)
https://www.gov.uk/government/publications/mhra-statement-on-products-containing-cannabidiol-cbd/mhra-statement-on-products-containing-cannabidiol-cbd
14 April 2025